Safety of BNT162b2 or CoronaVac COVID-19 vaccines in patients with heart failure: a self-controlled case series study

Ye, Xuxiao; Huang, Caige; Wei, Yue; Li, Silvia T.H.; Yan, Vincent Ka Chun; Yiu, Kai‐Hang; Tse, Hung‐Fat; Ma, Tiantian; Qin, Xiwen; Chui, Celine S L; Lai, Francisco Tsz Tsun; Li, Xue; Wan, Eric Yuk Fai; Wong, Carlos King Ho; Wong, Ian C. K.; Chan, Esther W.

doi:10.1016/j.lanwpc.2022.100630

Cited by 5 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[5][6][7][8][9] Moreover, evidence from studies including individuals with cardiovascular disease supports the safety and effectiveness of COVID-19 vaccines in this population group. 10,11 That is, the Heart Failure Association of the European Society of Cardiology and the American Heart Association suggest COVID-19 vaccination as soon as possible to individuals with heart failure, heart disease, heart attack, and cardiovascular risk factors since they are high risk groups to develop COVID-19 outcomes. 12 Although vaccination promotes public health and it is a cost-effectiveness intervention even in case of COVID-19, [13][14][15] vaccine hesitancy is still one of the biggest threats to global health 16 .…”

Section: Introductionmentioning

confidence: 99%

COVID-19-related burnout reduces COVID-19 vaccination intention in cardiac patients: a cross-sectional study in Greece

Galanis

Katsiroumpa

Vraka

et al. 2023

Preprint

View full text Add to dashboard Cite

Background: New SARS-CoV-2 variants have emerged and COVID-19 is still a public health issue, especially for vulnerable groups such as people with chronic medical conditions. Objective: To investigate the impact of COVID-19-related burnout on COVID-19 vaccination intention in cardiac patients. Moreover, we investigated other possible demographic and psychological predictors of vaccination intention in cardiac patients. Methods: We conducted a cross-sectional study in Greece using a convenience sample. Data collection was performed from 20 November 2022 to 10 January 2023. We measured demographic data, COVID-19-related burnout, anxiety, depression, social support, and resilience. We used the following valid tools: COVID-19 burnout scale, Patient Health Questionnaire-4, Multidimensional Scale of Perceived Social Support, and Brief Resilience Scale. Results: Among patients, 45.8% were willing to accept a COVID-19 booster dose, 25.3% were hesitant, and 28.9% were unwilling. Patients experienced moderate levels of COVID-19-related burnout. After multivariable linear regression analysis, we found that increased age and decreased emotional exhaustion due to COVID-19 were associated with increased vaccination intention. Moreover, patients who have already received a booster dose had also a greater willingness to accept a new booster dose. Conclusions: Identification of factors that influence patients decision to accept a COVID-19 booster dose is crucial to maintain a high vaccination coverage rate among them in order to avoid COVID-19-related outcomes. Since a COVID-19 booster dose on an annual basis seems to be necessary policy makers should develop and implement vaccination programmes tailored for patients.

show abstract